Page last updated: 2024-12-05

cupric sulfide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Cupric sulfide, also known as copper(II) sulfide, is an inorganic compound with the chemical formula CuS. It is a black solid that occurs naturally as the mineral covellite. Cupric sulfide is a semiconductor with a band gap of around 2.0 eV. It is synthesized by reacting copper(II) salts with sulfide ions in aqueous solution. Cupric sulfide is used in various applications, including solar cells, catalysts, and pigments. It is also studied for its potential applications in electronic devices and energy storage. Cupric sulfide is a relatively stable compound, but it can be oxidized in air to form copper(II) sulfate.'

copper(II) sulfide : A copper sulfide in which the metal is in the +2 oxidation state. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID14831
MeSH IDM0068921

Synonyms (33)

Synonym
ec 215-271-2
unii-kl4yu612x7
c.i. 77450
1317-40-4
nsc47694
horace vernet's blue
copper(ii) sulfide
cupric sulfide
copper monosulfide
hsdb 5805
natural covellite
ai3-51685
einecs 215-271-2
nsc 47694
copper sulphide
copper(ii) sulfide, powder, 99.99% trace metals basis
copper(ii) sulfide, powder, -100 mesh, >=99% trace metals basis
sulfanylidenecopper
covellite
19138-68-2
covelline
AKOS015903627
copper sulfide, 99.5%
BWFPGXWASODCHM-UHFFFAOYSA-N
copper(ii) sulfide, ultra dry
covellite (cus)
mfcd00016066
copper(ii)sulfide
Q416688
covellite (cus) (9ci)
DTXSID601316949
copper sulfide (ii), 99.99% metals basis
CS-0376110

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" These indexes, which represent new objective parameters for the characterization of lethality, should be substituted to the LD50 whose values vary between zero and infinite according to the time arbitrarily chosen for their calculation, and wear only a very restrictive significance."( [Toxicology of cupric sulfate in honeybees. I. New algebraic parameters of lethality as alternatives to the LD50].
Bounias, M; Nectoux, M, 1988
)
0.27
" The biological and physicochemical properties of nanoparticles bring new challenges with regards to management of potential adverse health effects following exposure."( Synthesis, characterization and cytotoxicity of alanine-capped CuS nanoparticles using human cervical carcinoma HeLa cells.
Mofokeng, TP; Moloto, MJ; Shumbula, PM; Tetyana, P, 2019
)
0.51
" In this work, we reported a novel kind of BiOI@CuS nanoparticle to achieve safe and effective therapy of lung cancer by co-loading hydrochloric acid doxorubicin (DOX) and aspirin phenacetin and caffeine (APC)."( Construction of DOX/APC co-loaded BiOI@CuS NPs for safe and highly effective CT imaging and chemo-photothermal therapy of lung cancer.
Cheng, J; He, D; Huang, G; Li, W; Wang, R; Zhang, Y; Zhu, J, 2019
)
0.51

Compound-Compound Interactions

ExcerptReferenceRelevance
"To investigate the anti-anxiety and anti-depression effect and mechanism of Xiaoyao San on rats with ovariectomy(OVX) combined with chronic unpredictable stress(CUS) model."( [Effect of Xiaoyao San on OVX combined with CUS anxiety and depression model rats based on hippocampal microglia M1 polarization].
Fei, GE; Fei, Q; Hao-Ran, Y; Jing, Y; Li-Na, L; Qin-Lei, C; Wei-Ting, LU, 2020
)
0.56

Dosage Studied

ExcerptRelevanceReference
" A low dosage of loaded DTX in FA-CD@PP-CpG can promote infiltration of CTLs to improve efficacy of anti-PD-L1 antibody (aPD-L1), suppress MDSCs, and effectively polarize MDSCs toward M1 phenotype to reduce tumor burden, further to enhance the antitumor efficacy."( Tumor-Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel-Enhanced Immunotherapy with Polarization toward M1-Type Macrophages on Triple Negative Breast Cancers.
Chen, L; Dong, C; Han, Y; Hu, X; Liang, S; Lin, Y; Liu, J; Lu, Y; Shi, S; Wang, C; Yao, T; Zhou, L, 2019
)
0.51
"Cancer photo-immunotherapy (CPIT) as an ideal strategy can rapidly release hostile signals by appropriate dosage of focal laser irradiation to unmask primary tumor immunogenicity and can activate adaptive immunity to control distant metastases."( Self-Splittable Transcytosis Nanoraspberry for NIR-II Photo-Immunometabolic Cancer Therapy in Deep Tumor Tissue.
Jiang, W; Liu, H; Lu, L; Peng, S; Su, Y; Wang, L; Zhan, M, 2022
)
0.72
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (266)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (2.26)18.7374
1990's1 (0.38)18.2507
2000's20 (7.52)29.6817
2010's145 (54.51)24.3611
2020's94 (35.34)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 62.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index62.37 (24.57)
Research Supply Index5.60 (2.92)
Research Growth Index6.45 (4.65)
Search Engine Demand Index103.05 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (62.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (1.48%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other266 (98.52%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]